Nuvation Bio to Present at the Jefferies London Healthcare Conference
Nuvation Bio (NYSE: NUVB), a late clinical-stage biopharmaceutical company focused on oncology, has announced its participation in the Jefferies London Healthcare Conference. David Hung, M.D., the company's Founder, President, and Chief Executive Officer, will deliver a presentation on Tuesday, November 19, 2024, at 3:30 a.m. ET/8:30 a.m. GMT in London, U.K. The presentation will be accessible via live webcast on the company's investor website, with a recording available for 90 days after the event.
Nuvation Bio (NYSE: NUVB), un'azienda biofarmaceutica in fase clinica avanzata e focalizzata sull'oncologia, ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference. David Hung, M.D., Fondatore, Presidente e Amministratore Delegato dell'azienda, terrà una presentazione martedì 19 novembre 2024, alle 3:30 a.m. ET/8:30 a.m. GMT a Londra, Regno Unito. La presentazione sarà disponibile in diretta tramite webcast sul sito web degli investitori dell'azienda, con una registrazione accessibile per 90 giorni dopo l'evento.
Nuvation Bio (NYSE: NUVB), una compañía biofarmacéutica en etapa clínica avanzada centrada en oncología, ha anunciado su participación en la Jefferies London Healthcare Conference. David Hung, M.D., fundador, presidente y director ejecutivo de la compañía, ofrecerá una presentación el martes 19 de noviembre de 2024, a las 3:30 a.m. ET/8:30 a.m. GMT en Londres, Reino Unido. La presentación estará disponible a través de una transmisión web en vivo en el sitio web de los inversores de la compañía, con una grabación accesible durante 90 días después del evento.
Nuvation Bio (NYSE: NUVB), 종양학에 집중하는 임상 후기 단계의 생물 제약 회사는 Jefferies London Healthcare Conference에 참가한다고 발표했습니다. David Hung, M.D.는 회사의 설립자이자 사장, CEO로서 2024년 11월 19일 화요일 오전 3:30 ET/오전 8:30 GMT에 런던에서 발표를 할 예정입니다. 발표는 회사 투자자 웹사이트를 통해 실시간 웹캐스트로 접근 가능하며, 이벤트 후 90일 동안 녹화본이 제공됩니다.
Nuvation Bio (NYSE: NUVB), une entreprise biopharmaceutique en phase clinique avancée axée sur l'oncologie, a annoncé sa participation à la Jefferies London Healthcare Conference. David Hung, M.D., fondateur, président et directeur général de l'entreprise, fera une présentation le mardi 19 novembre 2024, à 3h30 ET/8h30 GMT à Londres, Royaume-Uni. La présentation sera accessible en direct via un webinaire sur le site Web des investisseurs de l'entreprise, avec un enregistrement disponible pendant 90 jours après l'événement.
Nuvation Bio (NYSE: NUVB), ein biopharmazeutisches Unternehmen in der späten klinischen Phase mit Schwerpunkt auf Onkologie, hat seine Teilnahme an der Jefferies London Healthcare Conference angekündigt. David Hung, M.D., Gründer, Präsident und CEO des Unternehmens, wird am Dienstag, den 19. November 2024, um 3:30 Uhr ET/8:30 Uhr GMT in London, Großbritannien, eine Präsentation halten. Die Präsentation wird über einen Live-Webcast auf der Investorenseite des Unternehmens verfügbar sein, und eine Aufzeichnung wird 90 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
A live webcast of the presentation will be available on the Nuvation Bio website at https://investors.nuvationbio.com/investors/. An archived recording will be available for 90 days following the event.
About Nuvation Bio
Nuvation Bio is a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel product candidates. Nuvation Bio’s portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-1511 (DDC), and NUV-868 (BET). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241112616629/en/
Nuvation Bio Investor Contact:
ir@nuvationbio.com
Nuvation Bio Media Contact:
media@nuvationbio.com
Source: Nuvation Bio Inc.
FAQ
When is Nuvation Bio (NUVB) presenting at the Jefferies London Healthcare Conference 2024?
How can I watch Nuvation Bio's (NUVB) presentation at the Jefferies London Healthcare Conference?
How long will Nuvation Bio's (NUVB) Jefferies conference presentation recording be available?
Who will represent Nuvation Bio (NUVB) at the 2024 Jefferies London Healthcare Conference?
